ArticleCardiovascular diabetology2026
Benefits of sacubitril/valsartan alone and in combination with dapagliflozin in a preclinical female model of cardiometabolic and age-related cardiac dysfunction.
Elena Mele et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.